Signal
FDA approves Rocket's gene therapy Kresladi for rare immune disorder
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-03-26 22:47 UTCUpdated 2026-03-27 14:47 UTC
rss
clinical_trialsfdaapprovalsdrug_developmentsafety_signals
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (3 domains)domains are deduped. counts indicate coverage, not truth.3 top sources shown
Overview
Rocket Pharmaceuticals has received accelerated FDA approval for Kresladi (marnetegragene autotemcel), its first hematopoietic stem cell-based gene therapy, to treat children with severe leukocyte adhesion deficiency-1 (LAD-1).
Entities
Rocket PharmaceuticalsKresladi
Score total
1.25
Momentum 24h
3
Posts
3
Origins
3
Source types
1
Duplicate ratio
0%
Why now
- FDA's accelerated approval enables earlier patient access to Kresladi.
- Follows Rocket's recent efforts to recover value through innovative gene therapies.
- Reflects growing momentum in gene therapy approvals for rare diseases.
Why it matters
- Provides a new treatment option for children with a rare, severe immune disorder.
- Marks a significant regulatory milestone for Rocket Pharmaceuticals after prior setbacks.
- Highlights progress in gene therapy development and FDA's support for innovative treatments.
LLM analysis
Topic mix: lowPromo risk: lowSource quality: high
Recurring claims
- Rocket's gene therapy Kresladi received accelerated FDA approval to treat severe leukocyte adhesion deficiency-1 in children.
How sources frame it
- BioPharma Dive: neutral
- Fierce Pharma: neutral
- Pharmaphorum: neutral
All evidence
All evidence
Rocket has announced that the FDA signed off on an accelerated approval for its hematopoietic stem cell-based gene therapy Kresladi, also known as marnetegragene autotemcel, to ...
Fierce Pharma (All) · fiercepharma.com · 2026-03-27 14:47 UTC
Rocket gene therapy cleared by FDA for rare immune disorder
BioPharma Dive · biopharmadive.com · 2026-03-27 12:07 UTC
Touchdown for Rocket as its first gene therapy gets US okay
pharmaphorum · pharmaphorum.com · 2026-03-27 10:41 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 3Origin domains: 3Duplicates: -
Showing 3 / 0
Top publishers (this list)
- Fierce Pharma (All) (1)
- BioPharma Dive (1)
- pharmaphorum (1)
Top origin domains (this list)
- fiercepharma.com (1)
- biopharmadive.com (1)
- pharmaphorum.com (1)